Nexien BioPharma, Inc. (NXEN) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Glendale, CO, 미국. 현재 CEO는 Richard S. Greenberg.
NXEN 을(를) 보유 IPO 날짜 2017-11-29, 에 상장 Other OTC, 시가총액 $7.08K.
Nexien BioPharma, Inc. operates as a pharmaceutical company. It focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, and pre-clinical and clinical pathways for the treatment of various diseases, medical conditions, and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.
